skip to Main Content

UK Pharma Industry Bracing for Possible Disruption

From FierceBiotech: GlaxoSmithKline CEO Andrew Witty fears that if the European Medicines Agency (EMA) is moved from London, it will cause a tremendous disruption for the UK’s pharma and biotech industry. Experts worry about the possibility of regulatory upheaval if…

Read More

Cannabis Extracts Classified as Medicine in the UK

Across the pond, Cannabidiol (CBD)/Cannabis Extracts are set to be classified as a medicine within the UK. This comes after a decision by the Medicines & Healthcare products Regulatory Agency (MHRA) after reviewing claims of CBD successfully treating serious diseases. This means that…

Read More
Back To Top